| Literature DB >> 35313433 |
Hyeong Yong Jin1, Abulfetouh M Ibahim2, Jung Hoon Bae3, Chul Seung Lee3, Seung Rim Han3, In Kyu Lee3, Do Sang Lee3, Yoon Suk Lee3.
Abstract
Background: Laparoscopic complete mesocolic excision (CME) with D3 lymph node dissection for the right colon is becoming popular, but still technically challenging. Several articulating laparoscopic instruments had been introduced to reduce technical difficulties; however, those were not practical. This study aimed to report the first clinical experience of using ArtiSential®, a new laparoscopic articulating instrument in laparoscopic complete mesocolic with D3 lymph node dissection for right colon cancer. Patients andEntities:
Keywords: ArtiSential®; Articulating instrument; D3 lymph node dissection; colorectal surgery; complete mesocolic excision; laparoscopy
Year: 2022 PMID: 35313433 PMCID: PMC8973474 DOI: 10.4103/jmas.JMAS_88_21
Source DB: PubMed Journal: J Minim Access Surg ISSN: 1998-3921 Impact factor: 1.407
Figure 1ArtiSential®, LIVSMED Inc., Seongnam, Republic of Korea
Figure 2Surgical view of D3 lymph node dissection for right colon cancer
Figure 3Dissection around duodenum during complete mesocolic excision
Figure 4Dissection around ileocolic artery and vein
Figure 5(a-c) Dissection around mid-colic artery using ArtiSential®
Patient’s characteristics
| Variables | AG ( | CG ( |
|
|---|---|---|---|
| Age (years) | 71.6±9.8 | 70.3±11.3 | 0.61 |
| Sex (female) | 19 (57.6) | 20 (46.5) | 0.34 |
| BMI (kg/m2) | 23.5±3.4 | 25.4±11.8 | 0.36 |
| ASA score (≥3) | 5 (15.2) | 6 (14.0) | 1.00 |
| Operation type | |||
| Right hemicolectomy | 28 (75.8) | 30 (69.8) | 0.56 |
| Extended right hemicolectomy | 8 (24.2) | 13 (30.2) |
Proportion (%) are presented for categorical data. Mean±SD are presented for numerical data. BMI: Body mass index, ASA: American Society of Anaesthesiologist, SD: Standard deviation, AG: Articulating instrument group, CG: Conventional instrument group
Perioperative outcomes
| Variables | AG ( | CG ( |
|
|---|---|---|---|
| Operation time (min) | 141.0±22.5 | 156.0±50.6 | 0.09 |
| Estimated blood loss (ml) | 46.8±36.2 | 100.8±300.6 | 0.31 |
| Transfusion | 0 | 1 (2.3) | 1.00 |
| Length of hospital stay (days) | 3.0±1.2 | 4.1±2.2 | 0.01 |
| Intraoperative complications | 2 (6.1) | 2 (4.7) | 1.00 |
| Converted to open surgery | 1 (3.0) | 1 (2.3) | 1.00 |
| Post-operative complications | 9 (27.3) | 6 (14.0) | 0.15 |
| CDC I–II | 9 (27.3) | 5 (11.6) | |
| CDC III–IV | 0 | 0 | |
| CDC V | 0 | 1 (2.3) | |
| Proximal resection margin (cm) | 12.1±4.7 | 12.3±6.0 | 0.91 |
| Distal resection margin (cm) | 12.3±4.3 | 11.2±5.9 | 0.39 |
| Harvested lymph nodes | 32.6±12.2 | 24.6±7.4 | <0.01 |
| Metastatic lymph nodes | 0.9±1.8 | 1.2±2.6 | 0.60 |
| Differentiation, poorly | 7 (21.2) | 8 (18.6) | 0.78 |
| Vascular invasion | 8 (24.2) | 9 (20.9) | 0.73 |
| Lymphatic invasion | 12 (36.4) | 18 (41.9) | 0.63 |
| Neural invasion | 5 (15.2) | 4 (9.3) | 0.49 |
| TNM stage | |||
| I | 9 (27.3) | 7 (16.3) | 0.51 |
| II | 14 (42.4) | 21 (48.8) | |
| III | 10 (30.3) | 15 (34.9) |
Proportion (%) are presented for categorical data. Mean±SD are presented for numerical data. CDC: Clavien-Dindo classification, TNM: Tumour–node–metastasis, SD: Standard deviation, AG: Articulating instrument group, CG: Conventional instrument group